Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
United Therapeutics Corp (NASDAQ: UTHR) closed the day trading at $308.59 down -0.46% from the previous closing price of $310.03. In other words, the price has decreased by -$0.46 from its previous closing price. On the day, 0.65 million shares were traded.
Ratios:
For a better understanding of UTHR, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.86. For the most recent quarter (mrq), Quick Ratio is recorded 5.03 and its Current Ratio is at 5.25. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on July 11, 2024, Downgraded its rating to Equal-Weight and sets its target price to $321 from $310 previously.
On February 12, 2024, Goldman Upgraded its rating to Neutral which previously was Sell and also upped its target price recommendation from $213 to $215.
On February 05, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $330.Leerink Partners initiated its Outperform rating on February 05, 2024, with a $330 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 03 ’25 when BENKOWITZ MICHAEL sold 9,679 shares for $311.99 per share. The transaction valued at 3,019,736 led to the insider holds 0 shares of the business.
KURZWEIL RAY sold 15,000 shares of UTHR for $4,755,151 on Feb 28 ’25. The Director now owns 12,080 shares after completing the transaction at $317.01 per share. On Feb 28 ’25, another insider, Thompson Tommy G, who serves as the Director of the company, sold 2,500 shares for $318.34 each. As a result, the insider received 795,838 and left with 8,480 shares of the company.
Valuation Measures:
As of this moment, United’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.55, and their Forward P/E ratio for the next fiscal year is 10.66. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.82 while its Price-to-Book (P/B) ratio in mrq is 2.15.
Stock Price History:
Over the past 52 weeks, UTHR has reached a high of $417.82, while it has fallen to a 52-week low of $221.53. The 50-Day Moving Average of the stock is -13.65%, while the 200-Day Moving Average is calculated to be -10.11%.
Shares Statistics:
A total of 44.83M shares are outstanding, with a floating share count of 44.06M. Insiders hold about 1.89% of the company’s shares, while institutions hold 99.77% stake in the company.